HMOX1 and hypertensive disorder: Knockdown of Fasn or treatment with C75, a Fasn inhibitor, reduced ROS levels and pyroptosis by activating the Nrf2/HO-1 pathway, ultimately improving endothelial dysfunction and reversing hypertension-induced ED.